
Ema is the first AI specifically designed for women's health and wellness, differentiating itself from generic AI by deeply understanding the unique needs of women. It serves companies redefining care for women across various sectors, from diagnostics to wellness products. Ema's platform is purpose-built, evidence-backed, and doctor-vetted, trained on over 10 million real conversations with women and grounded in nursing and biopsychosocial models. It offers an intelligence layer for technology, revolutionizing care with personalized AI support for improved outcomes and engagement. The company highlights significant cost savings compared to custom builds, faster deployment times, and positive user outcomes like increased talk to doctors and seeking care for depression. Clients like PatientsLikeMe have integrated Ema's AI to deliver more personalized care, driving deeper engagement, education, and empowerment.

Ema is the first AI specifically designed for women's health and wellness, differentiating itself from generic AI by deeply understanding the unique needs of women. It serves companies redefining care for women across various sectors, from diagnostics to wellness products. Ema's platform is purpose-built, evidence-backed, and doctor-vetted, trained on over 10 million real conversations with women and grounded in nursing and biopsychosocial models. It offers an intelligence layer for technology, revolutionizing care with personalized AI support for improved outcomes and engagement. The company highlights significant cost savings compared to custom builds, faster deployment times, and positive user outcomes like increased talk to doctors and seeking care for depression. Clients like PatientsLikeMe have integrated Ema's AI to deliver more personalized care, driving deeper engagement, education, and empowerment.
Product: Conversational AI purpose-built for women's health (fertility through menopause) for consumers and enterprise partners
Founder & HQ: Founded and led by Amanda Ducach; headquartered in Houston, TX
Training & Clinical Approach: Clinician-vetted, evidence-backed; trained on over 10 million real conversations with women
Team & Funding: ~17 employees; reported Seed round on 2024-12-30; total funding $2,750,000 (USD)
Women's health and wellness (fertility, pregnancy, postpartum, menopause) and related consumer and enterprise care experiences.
2019
Femtech / Digital Health
Reported Seed round dated 2024-12-30; multiple investors reported including Kubera Venture Capital and Victorum Capital.
“Backed by multiple investors; Crunchbase lists Kubera Venture Capital and Victorum Capital among recent investors”